Related Experiment Video
Updated: Mar 18, 2026

07:08
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
8.4K
Vitamin E Status and Neurodegenerative Disease.
1a John Tabor Laboratories, Department of Biological and Chemical Sciences , University of Essex , Wivenhoe Park, Colchester , Essex CO4 3SQ , UK.
Nutritional Neuroscience
|July 14, 2016
Summary
Vitamin E may slow neurodegenerative diseases worsened by oxidative stress. Research examines its effects on conditions like Friedreich
Area of Science:
- Neuroscience
- Biochemistry
- Clinical Medicine
Background:
- Oxidative stress significantly worsens major neurodegenerative diseases.
- Vitamin E, comprising alpha- and gamma-tocopherol, possesses antioxidant properties.
- Several conditions are linked to vitamin E deficiency and neurological impairment.
Purpose of the Study:
- To evaluate the potential of vitamin E in mitigating neurodegenerative disease progression.
- To explore vitamin E's role in excitotoxicity and specific vitamin E deficiency disorders.
- To review evidence for vitamin E's efficacy in various neurological conditions and traumatic brain injuries.
Main Methods:
- Review of existing literature on vitamin E, oxidative stress, and neurological diseases.
- Analysis of studies on vitamin E's effects on neuronal excitotoxicity in vitro.
- Examination of clinical data concerning vitamin E supplementation in deficiency states and neurodegenerative disorders.
Main Results:
- Vitamin E's antioxidant capacity suggests a role in combating oxidative stress-related neurodegeneration.
- Ataxia due to vitamin E deficiency (AVED) is associated with specific genetic and malabsorptive conditions.
- Evidence is being gathered on vitamin E's potential benefits for Friedreich's ataxia, Parkinson's, Alzheimer's, and other neurological disorders.
Conclusions:
- Vitamin E demonstrates potential as a therapeutic agent against oxidative stress in neurodegenerative diseases.
- Further research is warranted to elucidate the precise mechanisms and clinical benefits of vitamin E and its derivatives in neurological disorders.
- Vitamin E derivatives may offer neuroprotection in cases of traumatic nervous system injury.
Related Concept Videos
Vitamins
2.8K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.8K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Neural Regulation
44.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.1K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Role of Neurotransmitters in Memory
2.8K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.8K

